After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes
The FDA recently approved the first cellular therapy for Type 1 diabetes and others may not be far behind. But experts say challenges still exist to the widespread application of these treatments.
Source: biospace.com